References
- Lock-Andersen J, Partoft S, Jensen MG. Patterns of the first lymph node metastases in patients with cutaneous malignant melanoma of axial localization. Cancer 1988; 62: 2073–7
- Reintgen D, Cruse W, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994; 6: 759–67
- Balch CM, Soong S, Gerschenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622–34
- Lock-Andersen J, Rossing N, Drzewiecki KT. Preoperative cutaneous lymphoscintigraphy in malignant melanoma. Cancer 1989; 63: 77–82
- Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma - a multicenter trial. Ann Surg 1999; 230: 453–65
- Morton DL, Wen D, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392–9
- Thompson JF, Niewind P, Uren RF, et al. Single-dose isotope injection for both preoperative lymphoscintigraphy and intra-operative identification in melanoma patients. Melanoma Res 1997; 7: 500–6
- Balch CM, Buzaid AC, Soong S, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635–48
- DMG 2003 Sentinel Node Protokol - Sentinel node biopsi fra patienter med kutant invasivt malignt melanom med klinisk TNM-stadium TX, T1b-T4, N0, M0 The Danish Melanoma Group 2003. www.melanoma.dk.
- DMG 2003 Kirurgisk Protokol - Kirurgisk behandling af patienter med kutant malignt melanom The Danish Melanoma Group 2003. www.melanoma.dk.
- DMG 2003 Klinik og patologi - Registrering af kliniske data og patologi data hos patienter med kutant malignt melanom The Danish Melanoma Group 2003. www.melanoma.dk.
- Morton DL. Lymphatic mapping and sentinel node lymphadenectomy for melanoma: past, present and future. Ann Surg Oncol 2001; 8(suppl 9)22S–8S
- Gad D, Sjøgren P. Sentinel node diagnostik hos patienter med kutant malignt melanom. Ugeskr Laeger 2003; 165: 2567–70
- Chakera AH, Drzewiecki KT, Eigtved A, Juhl BR. Sentinel node biopsy for melanoma: a study of 241 patients. Melanoma Res 2004; 14: 521–6
- Lowe JB, Hurst E, Moley JF, Cornelius LA. Sentinel lymph node biopsy in patients with thin melanoma. Arch Dermatol 2003; 139: 617–21
- Caracò C, Celentano E, Lastoria S, et al. Sentinel lymph node biopsy does not change melanoma-specific survival among patients with Breslow thickness greater than four millimetres. Ann Surg 2004; 11: 198S–203S
- Gershenwald JE, Mansfield PF, Lee JE, Ross MI. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (≥4 mm) primary melanoma. Ann Surg Oncol 2000; 7: 160–5
- Topping A, Dewar D, Rose V, et al. Five years of sentinel node biopsy for melanoma: the St George's Melanoma Unit experience. Br J Plast Surg 2004; 57: 97–104
- Fincher TR, McCarty TM, Fisher TL, et al. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma. Am J Surg 2003; 186: 675–81
- Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative lymph node biopsy in 234 patients with stage I or II melanoma. J Clin Oncol 1998; 16: 2253–60
- Hettiaratchy SP, Kang N, O'Toole G, et al. Sentinel node biopsy in malignant melanoma: a series of 100 consecutive patients. Br J Plast Surg 2000; 53: 559–62
- Wrone DA, Tanabe KK, Cosimi B, et al. Lymphedema after sentinel lymph node biopsy for cutaneous melanoma. Arch Dermatol 2000; 136: 511–4
- Woltsche-Kahr I, Komericki P, Kränke B, et al. Anaphylactic shock following peritumoral injection of patent blue in sentinel lymph node biopsy procedure. Eur J Surg Oncol 2000; 26: 313–4
- McMasters KM. The Sunbelt Melanoma Trial. Ann Surg Oncol 2001; 8(suppl 9)41S–3S